Abstract
ObjectiveWe sought to determine the accuracy of the LOW‐HARM score (Lymphopenia, Oxygen saturation, White blood cells, Hypertension, Age, Renal injury, and Myocardial injury) for predicting death from coronavirus disease 2019) COVID‐19.MethodsWe derived the score as a concatenated Fagan's nomogram for Bayes theorem using data from published cohorts of patients with COVID‐19. We validated the score on 400 consecutive COVID‐19 hospital admissions (200 deaths and 200 survivors) from 12 hospitals in Mexico. We determined the sensitivity, specificity, and predictive values of LOW‐HARM for predicting hospital death.ResultsLOW‐HARM scores and their distributions were significantly lower in patients who were discharged compared to those who died during their hospitalization 5 (SD: 14) versus 70 (SD: 28). The overall area under the curve for the LOW‐HARM score was 0.96, (95% confidence interval: 0.94–0.98). A cutoff > 65 points had a specificity of 97.5% and a positive predictive value of 96%.ConclusionsThe LOW‐HARM score measured at hospital admission is highly specific and clinically useful for predicting mortality in patients with COVID‐19.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American College of Emergency Physicians Open
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
